Mazurek, M. (2023) “Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis”, Journal of Education, Health and Sport, 13(4), pp. 123–131. doi: 10.12775/JEHS.2023.13.04.013.